Sign in →

Test Code LAB7983 Neuro-Oncology DNA Analysis

Aliases

Somatic Testing

Special Collection Notes

Collect specimen according to standard operating procedure

Specimen Type

Whole Blood or Bone Marrow/Purple Top Tube (K2 EDTA). Tissue (Fresh Frozen, Paraffin Embedded (FFPE) or RPMI)

Processing Instructions

*Store and ship ambient. If transport is longer than 4 hours send refrigerated on cold pack.

*For frozen tissue please send on dry ice- ASAP *Receipt within 24 hours of cutting or as soon as possible. Delays may impact nucleic acid quality.

Specimen Volume

Optimal Volume: 4.0 ml Minimum Volume: 0.5 ml Formalin-fixed, paraffin-embedded tissue block (preferred) or 10 micron unstained slides. (10 count).

Additional Notes

A paired non-tumor “normal” specimen may be submitted concurrently with the tumor specimen to allow for comparison and classification of variants as germline or somatic.
- Normal specimens may include blood or buccal swabs for solid tumors and fingernails for hematopoietic tumors.
- Normal specimens MUST be submitted at the same time as the tumor specimen to allow for paired analysis.
- Analysis of normal specimens is performed at no additional charge.
- The ordering clinician has the option to select for reporting of the germline/somatic status of variants at the time of tumor testing or to leave the status unreported until after review of variants identified in the tumor.
- The order for reporting of the germline/somatic status may be added at any time so long as the normal specimen was submitted at the same time as the tumor.
- The ordering clinician is responsible for obtaining patient consent for the reporting of germline variants.

TAT

21 days

Method

Next Generation Sequencing

CPT

81455

Performing Section

PRECISION DIAGNOSTICS

Purpose/Principle

This panel includes DNA analysis of 143 genes that have been described in the diagnosis, prognosis, or treatment decision process for central nervous system tumors

Detection of single nucleotide variants (SNVs), small indels and flanking intronic regions in the following genes:

ACTB, ACVR1, AKT1, AKT2, AKT3, ALK, APC, AR, ARID1A, ARID1B, ARID2, ATM, ATR, ATRX, AURKA, AURKB, BAP1, BCL2, BCL6, BCOR, BCORL1, BRAF, BRCA1, BRCA2, BRD4, CBL, CCND1, CCND2, CCND3, CD274, CDK4, CDK6, CDKN1B, CDKN2A, CDKN2B, CDKN2C, CHEK2, CIC, CREBBP, CTNNB1, CYSLTR2, DAXX, DDX3X, DICER1, DNMT3A, DROSHA, EGFR, EPHA7, EZH2, FGFR1, FGFR2, FGFR3, FGFR4, FH, FUBP1, GLI1, GLI2, GNA11, GNAQ, GNAS, GPR161, H3F3A, H3F3B, HIST1H1C, HIST1H3B, HIST1H3C, IDH1, IDH2, IKBKAP, JAK2, JAK3, KBTBD4, KDM5A, KDM5C, KDM6A, KIT, KMT2A, KMT2C, KMT2D, KRAS, LZTR1, MAP2K1, MDM2, MDM4, MET, MLH1, MSH2, MSH6, MYB, MYBL1, MYC, MYCN, NF1, NF2, NOTCH1, NOTCH2, NRAS, NTRK1, NTRK2, NTRK3, PALB2, PDCD1, PDGFRA, PDGFRB, PIK3CA, PIK3CB, PIK3CG, PIK3R1, PIK3R2, PLAGL1, PLCB4, PMS2, POLE, POLR2A, PPM1D, PRKAR1A, PRKCA, PTCH1, PTEN, PTPN11, RB1, RET, SDHA, SDHB, SDHC, SDHD, SETD2, SMARCA4, SMARCB1, SMO, STAG2, STAT3, SUFU, TERC, TERT, TET2, TP53, TRAF7, TSC1, TSC2, VHL, WT1, ZMYM3